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Abstract 
Background: Literature has shown that computerized creatinine clearance alerts reduce errors during 
prescribing, and applying human factors principles may further reduce errors.  Our objective was to 
apply human factors principles to creatinine clearance alert design and assess whether the redesigned 
alerts increase usability and reduce prescribing errors compared to the original alerts.   
Methods: Twenty Veterans Affairs (VA) outpatient providers: 14 physicians, 2 nurse practitioners, and 4 
clinical pharmacists completed two usability sessions in a counterbalanced study to evaluate original and 
redesigned alerts. Each session consisted of fictional patient scenarios with three medications that 
warranted prescribing changes due to renal impairment, each associated with creatinine clearance alerts. 
Quantitative and qualitative data were collected to assess alert usability and the occurrence of 
prescribing errors. 
Results: There were 43% fewer prescribing errors with the redesigned alerts compared to the original 
alerts (p=0.001). Compared to the original alerts, redesigned alerts significantly reduced prescribing 
errors for allopurinol and ibuprofen (85% vs 40%, and 65% vs 25%, p= 0.012, 0.008 respectively), but 
not for spironolactone (85% vs 65%). Nine (45%) providers voiced confusion about why the alert was 
appearing when they encountered the original alert design. When laboratory links were presented on the 
redesigned alert, laboratory information was accessed 3.5 times more frequently.  
Conclusion: Although prescribing errors were high with both alert designs, the redesigned alerts 
significantly improved prescribing outcomes. This investigation provides some of the first evidence on 
how alerts maybe designed to support safer prescribing for patients with renal impairment.   
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Introduction  
Renal function can be assessed through multiple methods; one common approach is to estimate 
creatinine clearance. People with impaired renal function are 5.5 times more likely to die than those 
without. 1,2 Adverse drug events and inappropriate prescribing related to renal function are estimated to 
occur in 20% to 46% of patients with impaired renal function, 91% of which may be preventable.3-7  
Computerized alerts can reduce prescribing errors associated with nephrotoxic medications, renally 
cleared medications, and renal impairment.6, 8-12 However, the approach to presenting information to 
providers via alerts  may affect how providers assess and use that information.13-15  For example, if the 
alert information is unclear this can result in inappropriate prescribing and increased patient risks.16 
Alert effectiveness is related to its usability, defined as the ‘extent to which a [alert] can be used by 
specified users to achieve specified goals with effectiveness, efficiency and satisfaction’.17 Usability is 
influenced by the alert’s interface display, which can be modified using human factors principles to 
improve safety.18-20  
Previously, we conducted an investigation to assess the use of alerts in outpatient care, which 
identified 44 factors that influence the human-computer interaction between providers and alerts, along 
with several weaknesses of alert designs.20 For instance, providers suggested that the timing of 
creatinine clearance alerts be modified so they appear in response to specific medication orders, such as 
allopurinol and non-steroidal anti-inflammatory drugs. Thus, the present work was undertaken to 
redesign and evaluate creatinine clearance alerts.  We hypothesized that redesigned alerts, which 
incorporated human factors principles, would significantly reduce prescribing errors compared to the 
original alerts. This investigation was part of a larger study, published elsewhere,21 that examined 
efficiency, mental workload, perceived satisfaction, and prescribing errors across several alert types, but 
did not assess findings by alert type. Herein, we present findings specific to creatinine clearance alerts 
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for the first time.  Distinct contributions of this article also include prescribing errors for individual 
medications; an in-depth analysis of prescribing actions, including how prescribers responded to dose 
dependent versus contraindicated medications; and prescribers’ utilization of laboratory results for 
resolving alerts.   
Methods 
Study design  
Participants completed prescribing tasks for fictional patients.22 Each participant completed two, 30-
minute sessions (i.e., original and redesign) in a counterbalanced design, with a washout period of at 
least 2 weeks between sessions so participants would be less likely to remember the tasks in each 
session. They were informed that they could order, discontinue, or change any medications. All 
participants were able to choose a medical or pharmaceutical textbook worth up to $50 for each session 
as an acknowledgement of their time. 
The study was approved by the Indiana University Institutional Review Board and Veterans Affairs 
(VA) Research and Development Committee, and was conducted at the VA Health Services Research 
and Development Human-Computer Interaction and Simulation Laboratory.23 This manuscript was 
prepared using the STAtement on the Reporting of Evaluation studies in Health Informatics (STARE-
HI) guidelines.24 
Participants  
Twenty VA providers (6 men, 14 women) participated, consisting of 14 physicians, 4 clinical 
pharmacists, and 2 nurse practitioners. Clinical pharmacists were included in this study because they 
have prescribing privileges in VA outpatient care and also receive alerts. None of the research team 
members were study participants. Additionally, none of the participants had any involvement in the 
development of study materials or data analysis. This sample size is within the acceptable range reported 
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by other human-computer interaction studies25-28. Participants had a mean age of 41 (range: 29-56) and 
an average of 7.5 years experience (range: 1-13.5 years) with VA computerized provider order entry.21 
Providers were recruited through e-mail and face-to-face communication and were eligible to participate 
if they were staff at the VA primary care clinics, and had at least one year of experience with VA 
computerized provider order entry. Students and residents were excluded from the study. 
Apparatus 
Prototypes  
Two prototypes were developed within a mock electronic health record. The original alerts (Figure 
1.A) represented those in use at the VA. These alerts appear before the medication list is displayed, 
warning providers “pre-emptively”. Alert redesigns (Figure 1.B) were iteratively developed by a team 
that included human factors engineers and clinicians, and informed by our previous study, where we 
identified limitations of alert designs within outpatient care.20 Redesigns were further informed by 
literature evidence and a VA advisory panel.21, 29-31 Human factors principles incorporated in the 
redesigned alerts included presenting alerts in a tabular format32, embedding links to additional 
laboratory information30, adding information on medication risks31, and changing the timing of the alert 
so that it appeared in association with specific medications.  For both alert designs, participants could 
access the ‘Labs’ tab in the mock electronic health record, but this required exiting the ordering process.  
Scenarios  
A pharmacist and physician developed two fictional patient scenarios to evaluate the alerts and 
reviewed the scenarios for completeness. Predefined, objective criteria for errors were developed a-
priori from Micromedex guidelines33 (Table 1, column 5) and used as the standard for error 
determinations.  
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 Scenarios included three medications that required adjustment or discontinuation due to renal 
impairment (Table 1). For the original design, two creatinine clearance alerts were produced, each near 
the beginning of the associated scenario. These alerts presented a general warning about estimated 
creatinine clearance and other lab results when the prescriber first enters the computerized provider 
order entry system (see Figure 1A). In contrast, redesigned alerts appeared immediately after order 
details for each medication were entered; thus, three alerts could appear. Additional prescribing tasks 
were interspersed between alerts to mimic workflow that occurs during patient care. Scenarios were 
identical between the two sessions, aside from the patient's name. Scenarios were pilot tested by three 
clinicians, not included as study participants, prior to data collection to ensure scenarios were clear, 
clinically appropriate, and followed standards of care. 
Data Collection  
Participants were recorded using Morae® (Okemos, MI) software which captures video of the 
computer screen actions. We collected qualitative data using the Think-aloud technique, where 
participants are asked to verbalize their thoughts as they use the alerts.34-36 Debrief interviews were 
conducted if time permitted. All verbalized statements were recorded and transcribed for later analysis. 
Data Analysis  
Video data were evaluated to assess usability. These data were analyzed by one individual with 
previous usability evaluation experience who was not part of the alert redesign team. This individual 
reviewed the videos, examined computer screen actions, and transcribed Think-aloud statements to 
assess the usability of the alerts. A pharmacist who was involved in neither the scenario development 
nor the redesign effort reviewed the videos and used the predefined criteria to evaluate prescribing 
errors. Another pharmacist double-checked each categorization to ensure accuracy.37 Prescribing errors 
and accessing laboratory results were compared across the two alert designs using Wilcoxon signed-rank 
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test for all three medications and McNemar tests for individual medications. All statistical tests were 
conducted with SPSS version 20.0.  
Results 
Prescribing errors related to renal impairment  
Across the scenarios, participants made significantly fewer prescribing errors (n=26) when using the 
redesigned versus original creatinine clearance alerts (n=47, p=0.001; Figure 2A). There were 43% 
fewer prescribing errors with the redesigned alerts. Results for individual medications are shown in 
Figure 2B.   
Prescribing Actions for dose-dependent verses contraindicated medications 
As shown in Table 1, allopurinol required at least a dose reduction, while spironolactone and 
ibuprofen were contraindicated for the scenarios.  Table 2 outlines prescribing actions taken for each. 
Providers appropriately decreased the dose of allopurinol three times more often when they encountered 
the redesigned alerts.  Several prescribers incorrectly reduced the dose of spironolactone rather than 
canceling the order, although more prescribers cancelled spironolactone with the redesigned alert.   
Usability of Creatinine Clearance Alerts 
Usability findings are shown in Table 3.  
Accessing laboratory results  
With the original alerts, additional laboratory information could only be accessed through the ‘Labs’ 
tab, but when providers used the redesigned alerts, laboratory information was accessed 3.5 times more 
frequently using the ‘more labs’ hyperlink than the ‘Labs’ tab. Overall, there was a modest improvement 
in appropriately discontinuing the spironolactone with the redesigned alerts (Figure 2B), but this was not 
due to the ease of viewing laboratory results: 2 of 5 providers who viewed labs with the original alerts 
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proceeded with the order, while 7 of 11 providers who viewed labs with the redesigned alerts proceeded 
with the order for spironolactone (Table 2).  
Discussion  
To our knowledge, this scenario-based study is the first to systematically compare two different 
designs for creatinine clearance alerts. Other studies noted a 16% reduction in prescribing errors when 
renal dosing alerts occurred during medication dispensing, and as much as a 42% reduction in 
prescribing errors during medication ordering compared to no alert, but neither study compared different 
alert designs nor examined the application of human factors principles on prescribing safety.6, 11,12 Our 
result of 43% fewer prescribing errors with the redesigns, supported the hypothesis that applying human 
factors alert design would reduce prescribing errors. Approximately 26 million Americans have chronic 
kidney disease.1 Preventable medication errors occur in this population about 7 million times and cost 
about $18 million annually.38 If the alerts reduce medication errors by 43%, as in our study, this could 
prevent harm to approximately 3 million patients and save  nearly $8 million dollars annually.38 
Four features of the redesigned alerts likely contributed to safer prescribing. First, the redesigned 
alerts occur closer to the time of medication decision-making, whereas the original alerts may have 
appeared too early in prescribing workflow, thereby increasing errors.  The original alerts appeared 
before the provider attempted to order or select a medication. Recent literature advocates for preemptive 
alerts that appear before prescribing decisions which may minimize workflow interruptions.39 However, 
when the original alerts were presented prior to medication selection, providers vocalized confusion 
about the alert’s purpose and prescribing errors were significantly greater. This early timing for alerts 
requires the provider to remember that the patient has renal impairment and assumes providers will 
know which medications are contraindicated or require a dosage adjustment later in the workflow of the 
session when specific medications are ordered. Our findings provide evidence that safer prescribing 
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occurs when alerts are provided closer to the point of decision-making – in this case, later in prescribing 
workflow - when the provider is attempting to prescribe a potentially harmful medication. The 
redesigned alerts are ‘smarter’ than the original alerts in that the redesigns are specific to renally dosed 
medications, whereas the original alerts appear regardless of what is being ordered.  In cases where 
providers are not ordering any renal dosing medications, the redesign could also reduce inappropriate 
alerts as well as the number of alerts presented. Similarly, the later presentation of the alert indicated 
that providers may need some type of action, as indicated by the increased number of providers who 
adjusted doses when presented with the redesigned alerts. 
Second, safer prescribing may have occurred in some cases because participants accessed laboratory 
results more frequently with the redesign, which included embedded links to lab results. This may 
facilitate clinical workflow by providing better data access, and allowing providers to more rapidly view 
information for clinical decision-making. Literature suggests that patient specific information, should be 
summarized and readily accessible within the alert, if solicited.40 
Third, the redesigned alerts displayed information in a tabular format, instead of one string of 
laboratory information. This format likely allowed providers to readily identify pertinent information 
when responding to alerts. Providers indicated the original design was difficult to read, and in one case, 
incorrectly interpreted the patient’s renal function as acceptable; the original design assumes that the 
provider will recognize an abnormal creatinine clearance, whereas the redesigned alerts specify the 
creatinine clearance is ‘low’. 
Fourth, providing information regarding medication risk may promote safer prescribing. According 
to warning design literature, risk information is key to help individuals recognize the level of danger.19,29 
With the redesigned alerts, safer prescribing occurred for two medications with risks of hepatotoxicity 
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and renal failure, which providers may perceive as more serious than the risk of hyperkalemia with 
spironolactone.   
Despite improved safety for allopurinol and ibuprofen, errors still occurred. This may be because 
estimated creatinine clearance was slightly below the accepted threshold of 30 mL/min, and providers 
may be inclined to renew these medications as this simulated patient had no previous problems. Errors 
were unlikely due to providers completely overlooking the alerts, since participants were asked to think 
aloud as they encountered alerts.21  
Other factors may explain why errors remained high with spironolactone. Providers might have 
determined that hyperkalemia could be monitored and managed with other interventions like dietary 
restrictions rather than changing spironolactone.   In the scenario, spironolactone needed to be cancelled 
because potassium was trending upward and above normal limits on the day of prescribing (Table 1).  
Neither alert design provided potassium results on the initial alert interface; this may have promoted 
some types of prescribing errors. Providers might not have been aware of the associated risk of 
hyperkalemia with renal impairment with the original design.  Redesigned alerts occurred in association 
with spironolactone and stated a risk of hyperkalemia, but even with these changes, 65% of providers 
still proceeded with the order (Figure 2).  With the redesign, seven providers who viewed lab results, 
presumably noting the elevated potassium level, continued with the spironolactone order. This indicates 
that easy access to lab results from the alert is not sufficient to promote safer decisions, but may improve 
workflow. One implication of these findings is that alerts may be improved by specifying whether a 
medication is ‘contraindicated’ or requires a ‘dose reduction’, since prescribers demonstrated confusion 
about what actions were warranted. This could be explicitly stated as part of the alert warning. Our 
findings for spironolactone are consistent with results from a clinical trial, which reported that over 80% 
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of outpatient physicians overrode drug-drug interactions alerts where the risk was hyperkalemia, even 
when the alert showed a potassium value above 5 mEq/L.41   
Future Work  
The overall error rate in our study, 60%, was still relatively high, but lower than reported in other 
studies of inappropriate renal prescribing, which found error rates of approximately 75%.4 Future 
research should focus on elucidating providers’ decision-making process. Additionally, differences 
between provider types should also be explored. With the redesign, some providers wanted information 
on dosing guidelines to inform their decisions. Providing dosing guidance may further reduce errors. 
Results provide evidence that presenting alerts too early in the prescribing process may weaken safety, 
but the optimum timing for creatinine clearance alerts is unknown. Similarly, adding laboratory results 
to the initial ordering screen should be evaluated. The redesigned alerts should also be piloted and 
evaluated in live clinical environments.  Finally, because the Think-Aloud technique may confound time 
measurement42, time to address the alerts was not analyzed in this study, and future work should 
examine time required in both laboratory and clinical settings. 
Limitations  
Providers were aware that patients were simulated; potentially reducing the precision of their clinical 
decision-making compared to clinical practice.  Only three medications were used to evaluate creatinine 
clearance alerts and a larger number of medications may produce different results. Furthermore, our 
predefined criteria for errors may be more conservative than actual practice.   Providers' responses might 
differ for inpatient scenarios, although we do not have data to support this.  Finally, providers were 
recruited from one VA medical center and other providers may have responded differently.  
Conclusions  
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Overall, alerts redesigned according to human factors principles led to safer prescribing for scenarios 
involving renal impairment. This study provides some of the first evidence on how to design creatinine 
clearance alerts to promote safety. Results indicate that creatinine clearance alerts should appear in 
association with specific medications, rather than as a general, ‘preemptive’ alert. Alerts should also 
present information regarding risks. Easy access to laboratory results may aid workflow and increase 
viewing of labs. Redesigned alerts significantly reduced errors for ibuprofen and allopurinol. Study 
findings may be used to improve medication safety for patients with renal impairment.  
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Figure 1: Screen shots of the original and redesigned creatinine clearance alerts. A) Original alert 
design. This alert appears when the provider starts the prescribing process but before a specific 
medication is selected.  The provider must proceed past this alert before s/he is able to access the list of 
medications that can be ordered in the computerized provider order entry system.  This screen shot is 
nearly identical to the alerts currently used in the VA system. Providers can also access laboratory 
results through the electronic health record, but not while the creatinine clearance alert is displayed on 
the screen. B) Redesigned alert. This alert appears only when a renally dependent drug is being ordered 
for a patient with a reduced creatinine clearance. The alert provides the provider with risks associated 
with medication use, estimated creatinine clearance, and a link to more laboratory results. Providers are 
also able to either cancel or accept the order within the alert. C) More labs. This screen shot presents the 
information displayed to providers when the ‘more labs’ link in the redesigned alerts is selected. It 
shows laboratory results relevant to renal function along with reference ranges and the date the test was 
conducted. Providers can close this window to return to the redesigned alert. 
 
Figure 2: Percentage of prescribing errors (N=20 providers). A) Distribution of errors across all 
scenarios between the original and redesigned creatinine clearance alerts. (Maximum number of errors 
per provider for each alert design = 3). B) Percentage of prescribing errors for individual medications.  
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Table 1: Description of patient scenarios related to creatinine clearance alerts and predefined criteria for 
errors. 
1. Medication 2. Fictitious Patient 
Description 
3. Relevant 
Laboratory 
Information† 
4. Prescribing Task 5. Correct/ 
Incorrect 
Actions 
6. Prescribing 
Guidelines33 
Spironolactone 
 
This patient came in 
today for follow-up. He 
is a 62-year-old black 
male veteran that 
presented 2 months ago 
with congestive heart 
failure and lower 
extremity edema.  He 
has also been recently 
diagnosed with panic 
disorder and 
depression. 
Today: 
Est CrCL: 
29.5 
SCr: 2.4 
BUN: 40 
K+: 5.7 
 
2 weeks ago: 
K+: 5 
 
4 weeks ago: 
K+: 3.6 
 
6 weeks ago: 
K+: 3.7 
The patient has 
been taking 
spironolactone for 
heart failure.  
Spironolactone was 
prescribed about a 
month ago and he 
only has a few 
tablets left.   
Begin renewing 
spironolactone. 
Correct:  
Order 
cancelled‡ 
 
Incorrect: 
medication 
renewed 
(any dose) 
Contraindicated 
in hyperkalemia 
(K+>5.5) 
Allopurinol 
 
Patient is an 89-year-
old black male veteran 
who presented today 
for follow-up of 
hypertension. He had a 
myocardial infarction 6 
months ago as a result 
of uncontrolled 
hypertension and 
dyslipidemia, and now 
has ventricular 
arrhythmias. He has 
diet-controlled Type II 
diabetes mellitus, is 
also being treated for 
depression successfully 
with nefazodone, which 
he has taken for the 
past year without any 
problems.  The patient 
indicated he had just 
finished his treatment 
with ketoconazole, 
which was prescribed 
for oral candidiasis. 
Yesterday: 
Est CrCL: 
28.3 
SCr: 1.4 
BUN: 18 
K+: 4.2 
 
1 Year ago: 
SCr: 1 
BUN: 10 
K+: 4.1 
The patient has 
been taking 
allopurinol for gout 
since 1983 but has 
run out of refills on 
his prescription and 
needs it renewed.   
Begin renewing 
allopurinol for 
gout. 
Correct: 
Medication 
dose 
decreased 
to ≤200mg 
or order 
cancelled‡ 
 
Incorrect:  
medication 
renewed, 
dose 
increased 
Reduced CrCL: 
dose ≤  200 
mg/daily 
Ibuprofen He has chronic pain 
due to osteoarthritis 
and has been 
managing it with 
ibuprofen since 
2006. He asks you 
for a new 
prescription for his 
ibuprofen since he 
is about out and has 
no more refills.   
Begin renewing 
ibuprofen. 
Correct: 
Order 
cancelled‡ 
 
Incorrect: 
medication 
renewed 
(any dose)  
Ibuprofen use 
not 
recommended 
in advanced 
renal disease 
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*Information in columns 2-4 was provided to the providers as part of the scenario introduction and tasks 
or was available within the mock EHR system for the fictitious patient. Information in column 5 
(Correct/Incorrect Actions) was for researcher use only and was not provided to participants. Figure 1 
shows the information presented for each alert design.  
†Abbreviations: Est CrCL: estimated creatinine clearance SCr: serum creatinine; BUN: blood urea 
nitrogen; K+: Potassium 
‡Cancelling the medication was correct whether or not an alternative medication was ordered. Any 
alternative medication could be ordered and no assessment was made concerning the correct or incorrect 
prescribing of the alternative medication. 
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Table 2: Providers' responses to alerts (N=20 providers) 
 Spironolactone Allopurinol Ibuprofen 
 Original Redesign p-value Original Redesign p-value Original Redesign p-value 
ACTION TAKEN           
  Ordered as is  15 8  16 8  12 4  
  Decreased Dose†  2 5  3 9  1 1  
  Increased Dose  0 0  1 0  0 0  
  Did not order 3 7  0 3  7 15  
Correct Action†  3 7 0.289 3 12 0.012* 7 15 0.008* 
 Physicians (n=14) 1 4  3 8  6 10  
 Pharmacists (n=4) 2 2  0 2  0 3  
 Nurse Practitioner (n=2) 0 1  0 2  1 2  
LAB RESULTS          
Accessed additional 
laboratory  information 5 11 0.109 5 13 0.021* 1 6 0.063 
Via ‘Labs’ tab 5 3‡  5 4‡  1 2  
Via alert link N/A 10‡  N/A 10‡  N/A 4  
*Significant McNemar test 
†Dose reduced to ≤200mg for allopurinol was considered correct. Dose reductions of any size for 
spironolactone and ibuprofen were considered incorrect. Cancelling any of these three medications was 
correct whether or not an alternative was ordered. See Table 1 for pre-defined correct and incorrect 
actions.  
‡2 participants used both the Labs tab and the alert link for spironolactone, and 1 participant used both 
for allopurinol. 
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Table 3: Summary of usability findings for original and redesigned alerts for creatinine clearance 
 ORIGINAL ALERTS REDESIGNED ALERTS  
Design 
Feature 
Usability Findings Redesign 
Feature 
Usability Findings Potential Design 
or Safety 
Implications 
Timing:  
alert appears 
before the 
provider 
selects any 
specific 
medication  
 9 (45%) participants 
voiced frustration or 
confusion about the 
timing of the alert. 
Example quotes from 
two participants:   
“Why is this popping up 
now?” 
 “…I only want to see if 
it it’s a drug I have to 
renally adjust.”  
 
2 (10%) stated they 
would ignore the alert 
because it was not 
relevant for the 
medication they needed 
to order.  
  “I got the usual 
creatinine alert and I 
ignored it because it 
doesn’t really matter for 
simvastatin.”  
Timing:  
alert appears 
only when the 
provider has 
selected a 
renally 
dependent 
drug 
No participants voiced 
frustration or confusion 
about CrCL alerts 
being triggered by 
specific medications 
Presenting the 
alert in 
association with 
specific 
medications 
reduces 
confusion.  
Text and 
layout:  prose 
format 
(e.g, Figure 
1A) 
3 (15%) participants 
expressed that the CrCL 
alerts were difficult to 
read.  
“It's kind of written like 
all in one line which 
doesn't make it as easy 
to read.” 
Text and 
layout: tabular 
format and 
half the 
number of 
words used 
(e.g., Figure 
1B)  
No participants voiced 
concerns about 
readability, but two 
(10%) provided 
positive comments.   
E.g., “…[it’s] easier to 
read because it’s less 
wordy…” 
Text and layout 
influences 
perceptions of 
CrCL alerts; brief 
statements are 
viewed positively 
and may increase 
providers’ 
attention to alerts.  
Navigation: 
‘OK’ button 
is only option 
No usability issues 
occurred related to alert 
navigation.  
Navigation: 
‘Accept 
Order’ or  
‘Cancel 
Order’ 
buttons are 
options 
5 (25%) participants 
saw the alert and then 
decided to adjust the 
dose, but had difficulty 
figuring out how to do 
this from the alert. To 
modify the dose, 
navigation requires 
provider to ‘Accept 
Alerts should 
facilitate actions 
to adjust 
medication dose. 
With the redesign 
(Figure 1.B), 
there is a risk the 
provider may 
inadvertently 
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Order’ but then go back 
and change the order, 
or ‘Cancel Order’ and 
start again with order 
entry 
order or cancel a 
medication when 
attempting to 
adjust the dose. 
Results 
provided for 
Est CrCL, 
SCr, and 
BUN. 
A critical usability issue 
occurred with one 
participant who viewed 
the alert and then stated 
“His kidney function is 
fine.” Another 
participant stated: “[the 
creatinine of] 2.4 is the 
number I zoomed in 
on….I didn’t really read 
the rest.” 
Alert displays 
Est CrCL. 
Link on alert 
can be used to 
access 
information 
on SCr and 
BUN.  Link 
also provides 
K+ results, 
which were 
added. For 
displayed lab 
results 
reference 
ranges were 
also provided. 
- 6 (30%) participants 
indicated they liked the 
ability to access some 
other lab results from 
the alert 
- 5 (25%) vocalized a 
desire for more 
information on labs, 
but did not use the link 
- Two participants 
wanted to know the K+, 
when the risk was 
hyperkalemia with 
spironolactone, but 
only one accessed the 
‘more labs’ link  
- Two participants 
expected to see liver 
function tests for the 
alert related to 
allopurinol, but this 
was not provided  
For a given alert, 
the lab results a 
provider would 
like to see may 
vary widely. It is 
likely that the lab 
value(s) presented 
on the alert 
interface are most 
salient for 
decision-making, 
and reference 
ranges should be 
provided or 
abnormals clearly 
indicated. Ideally, 
alerts should also 
provide easy 
access to all 
available labs.    
Only lab 
results are 
displayed on 
the alert 
3 (15%) participants 
indicated it is helpful to 
have labs in the alert.  
“Having the estimated 
creatinine clearance 
and creatinine's nice 
when ordering 
something.  But that'd be 
nice to just simplify that 
a little bit.” 
Alert states 
that creatinine 
clearance is 
low, and 
states 
medication 
name and risk 
3 (15%) participants (2 
physicians, 1 
pharmacist) asked for 
additional 
references/assistance or 
dosing guidelines for 
allopurinol in addition 
to the labs. 
“I'm not sure how 
allopurinol causes 
hepatotoxicity.  So I 
would probably go to 
the pharmacist and 
double check and make 
sure that creatinine is 
okay without renal 
adjustment which is a 
big issue.” 
Providing risk 
information on 
the alert may help 
providers identify 
what additional 
labs to review. 
However, labs 
may not be 
sufficient for 
decision-making. 
Alerts should 
provide dosing 
recommendations 
or easy access to 
dosing guidelines. 
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*Abbreviations: Est CrCL: estimated creatinine clearance SCr: serum creatinine; BUN: blood urea 
nitrogen; K+: Potassium  
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Figure 2: 
A 
 
B  
 
*Significant difference in prescribing errors between original and redesigned alerts. 
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Clinical Significance 
• This study provides some of the first evidence on how to design creatinine clearance 
alerts to promote safety for patients with renal impairment.  
• Links to more information within alerts allow providers to more easily view relevant lab 
results related to renal function.  
• Alerts that describe potential adverse events associated with a medication may promote 
safer prescribing decisions for patients with renal impairment.   
